These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24603894)

  • 1. Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.
    Lejon V; Mumba Ngoyi D; Kestens L; Boel L; Barbé B; Kande Betu V; van Griensven J; Bottieau E; Muyembe Tamfum JJ; Jacobs J; Büscher P
    PLoS Pathog; 2014 Mar; 10(3):e1003947. PubMed ID: 24603894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study.
    Büscher P; Mertens P; Leclipteux T; Gilleman Q; Jacquet D; Mumba-Ngoyi D; Pyana PP; Boelaert M; Lejon V
    Lancet Glob Health; 2014 Jun; 2(6):e359-63. PubMed ID: 25103304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses.
    Radwanska M; Guirnalda P; De Trez C; Ryffel B; Black S; Magez S
    PLoS Pathog; 2008 May; 4(5):e1000078. PubMed ID: 18516300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of multiplex serological assay for the detection of human African trypanosomiasis.
    Nzou SM; Fujii Y; Miura M; Mwau M; Mwangi AW; Itoh M; Salam MA; Hamano S; Hirayama K; Kaneko S
    Parasitol Int; 2016 Apr; 65(2):121-7. PubMed ID: 26519611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of serological screening tests and reference laboratory tests to diagnose gambiense human African trypanosomiasis: a prospective clinical performance study.
    N'Djetchi MK; Camara O; Koffi M; Camara M; Kaba D; Kaboré J; Tall A; Rotureau B; Glover L; Traoré MB; Koné M; Coulibaly B; Adingra GP; Soumah A; Gassama M; Camara AD; Compaoré CFA; Camara A; Boiro S; Anton EP; Bessell P; Van Reet N; Bucheton B; Jamonneau V; Bart JM; Solano P; Biéler S; Lejon V
    Infect Dis Poverty; 2024 Jul; 13(1):53. PubMed ID: 38978124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of B cells during chronic murine Trypanosoma brucei gambiense infection.
    Cnops J; Kauffmann F; De Trez C; Baltz T; Keirsse J; Radwanska M; Muraille E; Magez S
    Parasite Immunol; 2016 Oct; 38(10):642-7. PubMed ID: 27353256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of a rapid diagnostic test for Trypanosoma brucei gambiense infection developed using recombinant antigens.
    Lumbala C; Biéler S; Kayembe S; Makabuza J; Ongarello S; Ndung'u JM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006386. PubMed ID: 29590116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan.
    Chappuis F; Pittet A; Bovier PA; Adams K; Godineau V; Hwang SY; Magnus E; Büscher P
    Trop Med Int Health; 2002 Nov; 7(11):942-8. PubMed ID: 12390600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis.
    Magez S; Radwanska M
    Future Microbiol; 2009 Oct; 4(8):1075-87. PubMed ID: 19824795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
    Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
    Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanosoma brucei gambiense excreted/secreted factors impair lipopolysaccharide-induced maturation and activation of human monocyte-derived dendritic cells.
    Dauchy FA; Contin-Bordes C; Nzoumbou-Boko R; Bonhivers M; Landrein N; Robinson DR; Rambert J; Courtois P; Daulouède S; Vincendeau P
    Parasite Immunol; 2019 Aug; 41(8):e12632. PubMed ID: 31099071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.
    Van Nieuwenhove LC; Rogé S; Balharbi F; Dieltjens T; Laurent T; Guisez Y; Büscher P; Lejon V
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1189. PubMed ID: 21695105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
    Van Nieuwenhove L; Büscher P; Balharbi F; Humbert M; Dieltjens T; Guisez Y; Lejon V
    PLoS Negl Trop Dis; 2012; 6(6):e1682. PubMed ID: 22720103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis.
    Bockstal V; Guirnalda P; Caljon G; Goenka R; Telfer JC; Frenkel D; Radwanska M; Magez S; Black SJ
    PLoS Pathog; 2011 Jun; 7(6):e1002089. PubMed ID: 21738467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains.
    So J; Sudlow S; Sayeed A; Grudda T; Deborggraeve S; Ngoyi DM; Desamber DK; Wickstead B; Lejon V; Mugnier MR
    mBio; 2022 Dec; 13(6):e0255322. PubMed ID: 36354333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T. brucei infections abrogate diverse plasma cell-mediated effector B cell responses, independently of their specificity, affinity and host genetic background.
    De Trez C; Khan S; Magez S
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008358. PubMed ID: 32589656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First evidence that parasite infecting apparent aparasitemic serological suspects in human African trypanosomiasis are Trypanosoma brucei gambiense and are similar to those found in patients.
    Kaboré J; Koffi M; Bucheton B; MacLeod A; Duffy C; Ilboudo H; Camara M; De Meeûs T; Belem AM; Jamonneau V
    Infect Genet Evol; 2011 Aug; 11(6):1250-5. PubMed ID: 21530681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the micro-CATT, CATT/Trypanosoma brucei gambiense, and LATEX/T b gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in West and Central Africa.
    Truc P; Lejon V; Magnus E; Jamonneau V; Nangouma A; Verloo D; Penchenier L; Büscher P
    Bull World Health Organ; 2002; 80(11):882-6. PubMed ID: 12481210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antigens expressed in Pichia pastoris for the diagnosis of sleeping sickness caused by Trypanosoma brucei gambiense.
    Rogé S; Van Nieuwenhove L; Meul M; Heykers A; Brouwer de Koning A; Bebronne N; Guisez Y; Büscher P
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e3006. PubMed ID: 25032684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.